Literature DB >> 26320247

B Cell-Intrinsic Expression of the HuR RNA-Binding Protein Is Required for the T Cell-Dependent Immune Response In Vivo.

Amy DeMicco1, Martin S Naradikian2, Vishal J Sindhava3, Je-Hyun Yoon4, Myriam Gorospe4, Gerald B Wertheim5, Michael P Cancro2, Craig H Bassing6.   

Abstract

The HuR RNA-binding protein posttranscriptionally controls expression of genes involved in cellular survival, proliferation, and differentiation. To determine roles of HuR in B cell development and function, we analyzed mice with B lineage-specific deletion of the HuR gene. These HuRΔ/Δ mice have reduced numbers of immature bone marrow and mature splenic B cells, with only the former rescued by p53 inactivation, indicating that HuR supports B lineage cells through developmental stage-specific mechanisms. Upon in vitro activation, HuRΔ/Δ B cells have a mild proliferation defect and impaired ability to produce mRNAs that encode IgH chains of secreted Abs, but no deficiencies in survival, isotype switching, or expression of germinal center (GC) markers. In contrast, HuRΔ/Δ mice have minimal serum titers of all Ab isotypes, decreased numbers of GC and plasma B cells, and few peritoneal B-1 B cells. Moreover, HuRΔ/Δ mice have severely decreased GCs, T follicular helper cells, and high-affinity Abs after immunization with a T cell-dependent Ag. This failure of HuRΔ/Δ mice to mount a T cell-dependent Ab response contrasts with the ability of HuRΔ/Δ B cells to become GC-like in vitro, indicating that HuR is essential for aspects of B cell activation unique to the in vivo environment. Consistent with this notion, we find in vitro stimulated HuRΔ/Δ B cells exhibit modestly reduced surface expression of costimulatory molecules whose expression is similarly decreased in humans with common variable immunodeficiency. HuRΔ/Δ mice provide a model to identify B cell-intrinsic factors that promote T cell-dependent immune responses in vivo.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26320247      PMCID: PMC4575876          DOI: 10.4049/jimmunol.1500512

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  75 in total

1.  Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81.

Authors:  T Miyazaki; U Müller; K S Campbell
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

Review 2.  Models for peripheral B cell development and homeostasis.

Authors:  Bhaskar Srivastava; R Coleman Lindsley; Neda Nikbakht; David Allman
Journal:  Semin Immunol       Date:  2005-06       Impact factor: 11.130

Review 3.  CD27 and CD70 in T cell and B cell activation.

Authors:  Jannie Borst; Jenny Hendriks; Yanling Xiao
Journal:  Curr Opin Immunol       Date:  2005-06       Impact factor: 7.486

4.  Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice.

Authors:  E N Tsitsikov; J C Gutierrez-Ramos; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

5.  Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

Authors:  J Jonkers; R Meuwissen; H van der Gulden; H Peterse; M van der Valk; A Berns
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

6.  CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.

Authors:  Menno C van Zelm; Julie Smet; Brigitte Adams; Françoise Mascart; Liliane Schandené; Françoise Janssen; Alina Ferster; Chiung-Chi Kuo; Shoshana Levy; Jacques J M van Dongen; Mirjam van der Burg
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

7.  B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation.

Authors:  F Borriello; M P Sethna; S D Boyd; A N Schweitzer; E A Tivol; D Jacoby; T B Strom; E M Simpson; G J Freeman; A H Sharpe
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

8.  Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5.

Authors:  Christopher D C Allen; K Mark Ansel; Caroline Low; Robin Lesley; Hirokazu Tamamura; Nobutaka Fujii; Jason G Cyster
Journal:  Nat Immunol       Date:  2004-08-01       Impact factor: 25.606

9.  B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1.

Authors:  Alex Karnowski; Stephane Chevrier; Gabrielle T Belz; Adele Mount; Dianne Emslie; Kathy D'Costa; David M Tarlinton; Axel Kallies; Lynn M Corcoran
Journal:  J Exp Med       Date:  2012-10-08       Impact factor: 14.307

10.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  13 in total

1.  RNA-Binding Protein HuR Promotes Th17 Cell Differentiation and Can Be Targeted to Reduce Autoimmune Neuroinflammation.

Authors:  Jing Chen; Jennifer L Martindale; Kotb Abdelmohsen; Gaurav Kumar; Paolo M Fortina; Myriam Gorospe; Abdolmohamad Rostami; Shiguang Yu
Journal:  J Immunol       Date:  2020-03-13       Impact factor: 5.422

2.  HuR controls apoptosis and activation response without effects on cytokine 3' UTRs.

Authors:  Fedor V Karginov
Journal:  RNA Biol       Date:  2019-03-04       Impact factor: 4.652

Review 3.  Drug delivery approaches for HuR-targeted therapy for lung cancer.

Authors:  Rajeswari Raguraman; Santny Shanmugarama; Meghna Mehta; Jo Elle Peterson; Yan D Zhao; Anupama Munshi; Rajagopal Ramesh
Journal:  Adv Drug Deliv Rev       Date:  2021-11-22       Impact factor: 15.470

Review 4.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

5.  Regulation of HuR structure and function by dihydrotanshinone-I.

Authors:  Preet Lal; Linda Cerofolini; Vito Giuseppe D'Agostino; Chiara Zucal; Carmelo Fuccio; Isabelle Bonomo; Erik Dassi; Stefano Giuntini; Danilo Di Maio; Vikalp Vishwakarma; Ranjan Preet; Sha Neisha Williams; Max S Fairlamb; Rachel Munk; Elin Lehrmann; Kotb Abdelmohsen; Saioa R Elezgarai; Claudio Luchinat; Ettore Novellino; Alessandro Quattrone; Emiliano Biasini; Leonardo Manzoni; Myriam Gorospe; Dan A Dixon; Pierfausto Seneci; Luciana Marinelli; Marco Fragai; Alessandro Provenzani
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

Review 6.  Alternative splicing: the pledge, the turn, and the prestige : The key role of alternative splicing in human biological systems.

Authors:  L M Gallego-Paez; M C Bordone; A C Leote; N Saraiva-Agostinho; M Ascensão-Ferreira; N L Barbosa-Morais
Journal:  Hum Genet       Date:  2017-04-03       Impact factor: 4.132

Review 7.  Cell cycle RNA regulons coordinating early lymphocyte development.

Authors:  Alison Galloway; Martin Turner
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-02-23       Impact factor: 9.957

Review 8.  Uncovering the Role of RNA-Binding Proteins in Gene Expression in the Immune System.

Authors:  Manuel D Díaz-Muñoz; Martin Turner
Journal:  Front Immunol       Date:  2018-05-23       Impact factor: 7.561

9.  Adipose HuR protects against diet-induced obesity and insulin resistance.

Authors:  Jingyuan Li; Li Gong; Shaozhuang Liu; Yujie Zhang; Chunmei Zhang; Mi Tian; Huixia Lu; Peili Bu; Jianmin Yang; Changhan Ouyang; Xiuxin Jiang; Jiliang Wu; Yun Zhang; Qing Min; Cheng Zhang; Wencheng Zhang
Journal:  Nat Commun       Date:  2019-05-30       Impact factor: 14.919

Review 10.  Hallmarks of cancer and AU-rich elements.

Authors:  Khalid S A Khabar
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-06-01       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.